Literature DB >> 12493586

Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.

Thierry Le Bricon1, Djaouida Bengoufa, Mourad Benlakehal, Bernard Bousquet, Danielle Erlich.   

Abstract

Evaluate the Freelite free light chain immunoassay for urine analysis in myeloma. Urine specimens from 20 patients were analyzed by Freelite (The Binding Site) and SDS-agarose gel electrophoresis (Hydragel protéinurie, Sebia). Using the kappa/lambda ratio, Freelite was more sensitive than electrophoresis to detect free light chains, but concentration was overestimated in 75% of cases. Despite high sensitivity and full automation, Freelite inaccurately measures monoclonal free light chains in urine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12493586     DOI: 10.1016/s0009-9120(02)00386-7

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Screening panels for monoclonal gammopathies: time to change.

Authors:  Jerry A Katzmann
Journal:  Clin Biochem Rev       Date:  2009-08

Review 2.  Diagnostic Advances in Multiple Myeloma.

Authors:  Kevin Barley; Ajai Chari
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

3.  A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.

Authors:  Nelson Leung; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-18       Impact factor: 8.237

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.